Save time and jump to the most important pieces.
4 - GAXOS.AI INC. (0001895618) (Issuer)
4 - GAXOS.AI INC. (0001895618) (Issuer)
4 - GAXOS.AI INC. (0001895618) (Issuer)
Roseland, NJ, Nov. 21, 2024 (GLOBE NEWSWIRE) -- Gaxos.ai Inc. ("Gaxos" or the "Company"), a company developing artificial intelligence applications across various sectors, today announced that the Company successfully integrated Suno AI and ElevenLabs into their artificial intelligence solution for game developers and publishers, Gaxos Labs. "We are pleased to welcome Suno AI and ElevenLabs into our Gaxos Labs ecosystem," said Vadim Mats, CEO of Gaxos. "As we continue on our path to becoming an all-in-one artificial intelligence solution for game developers and publishers, we will add other AI tools to make our product more robust and invaluable." Suno and ElevenLabs offers users the abi
Roseland, NJ, Nov. 14, 2024 (GLOBE NEWSWIRE) -- Gaxos.ai Inc. ("Gaxos" or the "Company"), a company developing artificial intelligence applications across various sectors, announced today that the Company's Board of Directors approved the purchase of up to $1 million in Bitcoin. "As demand for Bitcoin grows and so does its acceptance as a major and primary asset class, we believe that Bitcoin will serve as a strong treasury reserve asset," said Vadim Mats, CEO of Gaxos. "With recent approval of Bitcoin ETFs and growing support from institutional investors, it is a great addition to our treasury strategy. Its limited supply and inflation-resistant characteristics provide a functional sto
Roseland, NJ, Nov. 05, 2024 (GLOBE NEWSWIRE) -- Gaxos.ai Inc. ("Gaxos" or the "Company"), a company developing artificial intelligence applications across various sectors, today announced that it will participate in the upcoming AI Summit New York on December 11th-12th in New York City. "We are excited to be part of the AI Summit," said Vadim Mats, CEO of Gaxos. "As we engage globally with development communities, gamers, and industry leaders, we continue to forge meaningful relationships that bring value to our AI products." To meet with Gaxos at the conferences or for press inquiries, please email [email protected] About Game Industry Conference Since 2016, The AI Summit Series has ga
SC 13G - GAXOS.AI INC. (0001895618) (Subject)
Roseland, NJ, April 25, 2024 (GLOBE NEWSWIRE) -- Gaxos.ai Inc. ("Gaxos" or the "Company"), a company developing artificial intelligence applications across various sectors, today announced that Gaxos Health has expanded its Medical Advisory Board with the appointment of Dr. Eric Margolis and Dr. Jeff Pavell. "The addition of top medical talent to our Medical Advisory Board reflects our continued commitment to pursuing a best-in-class solution for Gaxos Health," said Vadim Mats, CEO of Gaxos.AI. "An advisory board of experts in their respective fields will allow to create a better product and advancing our mission of creating value for shareholders." Dr. Eric Margolis, M.D. is a Board-Ce
Gaxos.ai Inc. ("Gaxos" or the "Company"), a company developing artificial intelligence applications across various sectors, today announced that Gaxos Health has finalized partnerships with premier testing laboratories.
Gaxos.ai Inc. (NASDAQ:GXAI) shares are volatile Wednesday after the company announced it has partnered with Meshy to deliver 3D assets in its AI solution for game developers and publishers. The Details: Gaxos.ai and Meshy have partnered to use generative AI to transform text and images into 3D models in Gaxos.ai’s game development solution. “We are happy to announce our partnership with Meshy to deliver quality 3D models through our product,” said Vadim Mats, CEO of Gaxos.AI. “We look forward to working with Meshy to make our product and service and integral part of any game developer’s or publisher’s toolkit.” Read Next: What Happened With Trump Media & Technology Group Stock To
DEF 14A - GAXOS.AI INC. (0001895618) (Filer)
10-Q - GAXOS.AI INC. (0001895618) (Filer)
424B3 - GAXOS.AI INC. (0001895618) (Filer)
Roseland, NJ, March 13, 2024 (GLOBE NEWSWIRE) -- Gaxos.ai Inc. ("Gaxos" or the "Company"), a company developing artificial intelligence applications across various sectors, today announced that it had acquired the rights to use certain AI-enabled technology from a top biohacking app, "Ultiself," in order to facilitate the development of its tech for Gaxos Health. The integration of Ultiself's proprietary technology into Gaxos Health's proposed product offering will enable enhanced customization and user experience aligning with modern-day consumer's demands for custom and efficient solutions. This move is expected to accelerate Gaxos Health's development and help solidify its positio